ChristianaCare’s Gene Editing Institute has launched DECODR, Inc., a new for‑profit company created to expand access to one of the world’s leading software tools to evaluate the effectiveness of ...

Planned Interim Futility Analysis from Pivotal Phase 2 ALPHA3 Trial Supports Cemacabtagene Ansegedleucel’s (Cema-Cel) Potential as an Outpatient, ...

Allogeneic hematopoietic cell transplantation (alloHCT) using tremtelectogene empogeditemcel (trem-cel), a CRISPR–Cas9–edited ...

B cash runway to mid-2029, pivotal SCD & AATD programs, and attractive valuation—review risks and opportunities now.

Researchers analyzed pancreatic islets from 299 donors and found that differences in alpha, beta, and delta cell composition ...

Tuberculosis (TB) remains one of the leading causes of mortality from a single infectious agent worldwide and continues to pose a major public health ...

CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.

Fivetran, the data foundation for AI, today announced plans to become steward of the Great Expectations open source community and GX Core project, supporting the continued development of one of the ...

Infraway's L1 Lower Back Wearable Heat Pad combines Far Infrared (FIR) and topical heat to enhance mobility, support recovery, and facilitate warm-up. Unlike competitor products, Infraway is discreet ...

Bank of America Global Healthcare Conference 2026 May 12, 2026 5:20 PM EDTCompany ParticipantsSteven Harr - President, ...

Pumpkinseed founders Jennifer Dionne, Jack Hu, and Nhat Vu discuss their nanophotonic chip platform that promises label-free, ...